Related references
Note: Only part of the references are listed.Let's go beyond the effect of: Reappraising the impact of ordinary activities on cognition
Rafael Roman-Caballero et al.
PSICOLOGICA (2023)
Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice
R. A. Moore et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
The Clinical Importance of Changes in the 0 to 10 Numeric Rating Scale for Worst, Least, and Average Pain Intensity: Analyses of Data from Clinical Trials of Duloxetine in Pain Disorders
John T. Farrar et al.
JOURNAL OF PAIN (2010)
Identification of Cutpoints for Acceptable Health Status and Important Improvement in Patient-Reported Outcomes, in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
Maria Knoph Kvamme et al.
JOURNAL OF RHEUMATOLOGY (2010)
How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?
Deborah L. Hoffman et al.
PAIN (2010)
Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain
R. Andrew Moore et al.
PAIN (2010)
Patient-Centered Perspective on Treatment Outcomes in Chronic Pain
Erin M. O'Brien et al.
PAIN MEDICINE (2010)
Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review
Sebastian Straube et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Enriched enrolment with randomised withdrawal (EERW): Time for a new look at clinical trial design in chronic pain
Henry J. McQuay et al.
PAIN (2008)
Placebo response in neuropathic pain trials
Steve N. Quessy et al.
PAIN (2008)
Bibliographic study showed improving methodology of meta-analyses published in leading journals 1993-2002
Stefan Gerber et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
Evaluation of the Patient Acceptable Symptom State in a pooled analysis of two multicentre, randomised, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis
Maxime Dougados et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
H Breivik et al.
EUROPEAN JOURNAL OF PAIN (2006)
Why most published research findings are false
JPA Ioannidis
PLOS MEDICINE (2005)
Direct likelihood analysis versus simple forms of imputation for missing data in randomized clinical trials
C Beunckens et al.
CLINICAL TRIALS (2005)
Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses
F Song et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Allocation concealment in randomised trials: defending against deciphering
KF Schulz et al.
LANCET (2002)
Meta-analyses involving cross-over trials: methodological issues
DR Elbourne et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2002)
Publication bias in meta-analysis: its causes and consequences
A Thornton et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)